Consolidated Statement Of Comprehensive Income

HISAMITSU PHARMACEUTICAL CO.,INC. - Filing #7566829

Concept 2022-03-01 to
2023-02-28
2022-03-01 to
2023-02-28
2022-03-01 to
2023-02-28
2022-03-01 to
2023-02-28
2022-03-01 to
2023-02-28
2021-03-01 to
2022-02-28
2021-03-01 to
2022-02-28
2021-03-01 to
2022-02-28
2021-03-01 to
2022-02-28
2021-03-01 to
2022-02-28
Consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
10,414,000,000 JPY
10,414,000,000 JPY
10,414,000,000 JPY
12,126,000,000 JPY
10,414,000,000 JPY
7,169,000,000 JPY
7,169,000,000 JPY
7,169,000,000 JPY
9,862,000,000 JPY
7,169,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
1,991,000,000 JPY
-1,065,000,000 JPY
Foreign currency translation adjustment
10,188,000,000 JPY
6,761,000,000 JPY
Remeasurements of defined benefit plans, net of tax
-456,000,000 JPY
475,000,000 JPY
Share of other comprehensive income of entities accounted for using equity method
-5,000,000 JPY
-7,000,000 JPY
Other comprehensive income
11,718,000,000 JPY
6,020,000,000 JPY
Comprehensive income
23,844,000,000 JPY
15,883,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
23,458,000,000 JPY
15,724,000,000 JPY
Comprehensive income attributable to non-controlling interests
386,000,000 JPY
158,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.